{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-010911","form_type":"8-K","ticker":"SRXH","cik":"0001471727","company_name":"SRx Health Solutions, Inc.","filed_at":"2026-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.141494+00:00","generated_at":"2026-05-15T09:50:54.982708+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"SRx Health Solutions raises up to $8.0M via Series B preferred and warrants; initial close $4.528M","bullets":["Securities Purchase Agreement for up to 10,000 Series B shares ($1,000 stated value) and warrants at $0.3182 exercise price.","Initial closing of 5,660 Series B shares and 22,237,666 warrants for gross proceeds of ~$4.528M.","Warrants expire 3 years from exercisability; exercise price subject to adjustment after stockholder approval.","Company optional redemption at 125% of greater of stated value or market price; conversion price fixed at $0.3182."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-010911","json":"https://secwatch.observer/filing/0001493152-26-010911.json","markdown":"https://secwatch.observer/filing/0001493152-26-010911.md","text":"https://secwatch.observer/filing/0001493152-26-010911.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1471727/000149315226010911/0001493152-26-010911-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1471727/000149315226010911/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:50:54.982708+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"25642889f2eca74f8d31b37f1e7d6b9ca6d2870a","claim":"SRx Health Solutions, Inc. issued 22,237,666 Warrants to purchase shares of Common Stock of warrant to accredited investors named therein for aggregate proceeds of approximately $4.528 million, paid in cash.","evidence_excerpt":"On March 16, 2026 at the initial closing, pursuant to the Securities Purchase Agreement, the Company issued and sold, and certain investors purchased, in a private placement (the “Private Placement”): 5,660 shares of the Series B Preferred Stock and 22,237,666 Warrants to purchase shares of Common Stock for aggregate proceeds of approximately $4.528 million, paid in cash.","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1471727/000149315226010911/0001493152-26-010911-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"22,237,666 Warrants to purchase shares of Common Stock"},{"label":"Purchaser","value":"accredited investors named therein"},{"label":"Consideration","value":"aggregate proceeds of approximately $4.528 million, paid in cash"}],"fact_type":"equity_issuance"},{"claim_id":"497ad56d414c4bc10350c68e194a65a23040503a","claim":"SRx Health Solutions, Inc. issued 5,660 shares of the Series B Preferred Stock of preferred stock to accredited investors named therein for aggregate proceeds of approximately $4.528 million, paid in cash.","evidence_excerpt":"On March 16, 2026 at the initial closing, pursuant to the Securities Purchase Agreement, the Company issued and sold, and certain investors purchased, in a private placement (the “Private Placement”): 5,660 shares of the Series B Preferred Stock and 22,237,666 Warrants to purchase shares of Common Stock for aggregate proceeds of approximately $4.528 million, paid in cash.","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1471727/000149315226010911/0001493152-26-010911-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Shares","value":"5,660 shares of the Series B Preferred Stock"},{"label":"Purchaser","value":"accredited investors named therein"},{"label":"Consideration","value":"aggregate proceeds of approximately $4.528 million, paid in cash"}],"fact_type":"equity_issuance"},{"claim_id":"a9bd53ee5ff10ee15f83495917b13952295aeb04","claim":"SRx Health Solutions, Inc. entered into Securities Purchase Agreement with certain accredited investors named therein valued at up to $8.0 million (effective 2026-03-16).","evidence_excerpt":"On March 16, 2026, SRx Health Solutions, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain accredited investors named therein. Pursuant to the Securities Purchase Agreement, up to 10,000 shares of the Company’s Series B convertible preferred stock, par value $0.001 per share (the “Series B Preferred Stock”) and accompanying warrants (“Warrants”) to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) may be purchased for an aggregate purchase price of up to $8.0 million in one or more closings (each a “Closing”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1471727/000149315226010911/0001493152-26-010911-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors named therein"},{"label":"Value","value":"up to $8.0 million"},{"label":"Effective","value":"2026-03-16"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}